Orchestra BioMed Inc.

NASDAQ: OBIO · Real-Time Price · USD
3.05
-0.21 (-6.44%)
At close: Jun 05, 2025, 3:59 PM
3.18
4.26%
After-hours: Jun 05, 2025, 05:39 PM EDT
-6.44%
Bid 3
Market Cap 116.85M
Revenue (ttm) 2.89M
Net Income (ttm) -66.32M
EPS (ttm) -1.77
PE Ratio (ttm) -1.72
Forward PE -1.84
Analyst Buy
Ask 3.45
Volume 224,240
Avg. Volume (20D) 382,853
Open 3.24
Previous Close 3.26
Day's Range 3.05 - 3.27
52-Week Range 2.37 - 8.87
Beta 0.63

About OBIO

undefined

Industry n/a
Sector n/a
IPO Date n/a
Employees NaN
Stock Exchange n/a
Ticker Symbol OBIO
Website n/a
Full Company Profile

Analyst Forecast

According to 0 analyst ratings, the average rating for OBIO stock is "n/a." The 12-month stock price forecast is $n/a, which is a decrease of 0% from the latest price.

Stock Forecasts
3 weeks ago
+10.94%
Orchestra BioMed shares are trading higher after t... Unlock content with Pro Subscription
1 month ago
+0.7%
Orchestra BioMed shares are trading higher after the company announced it secured FDA Breakthrough Device Designation for AVIM therapy.